ToMORROW Mastitis Treatment

Boehringer Ingelheim

Restricted Drug (California) - Use Only As Directed. We cannot ship this product to California. We apologize for the inconvenience.

Mastitis Treatment for Dry Cows

ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows.

ToMORROW Features and Benefits

  • ToMORROW has been an effective extended therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.
  • ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains.
  • ToMORROW Dosage and Administration

    Infuse a 10 mL syringe (300 mg cephapirin activity per syringe) once each quarter has been completely milked out.

    Collections: Cattle

    Category: broad spectrum, dairy, dry cow, mastisis, treatment

    Type: Therapeutics

    Related Items